ToxChats©

50 - Transitioning from Industry to Consulting, Independent vs. Firm Consultant

The American College of Toxicology podcast program, ToxChats ©, reports on cutting-edge news in toxicological research from around the globe.

Другие подкасты - %(genre)s

50 - Transitioning from Industry to Consulting, Independent vs. Firm Consultant

Fri, 27 Feb 2026
49 - Human and Environmental Health Topic: Next Generation Risk Assessment

Fri, 07 Nov 2025
48 - The Science of Mentorship: A Conversation with Richard DiMarchi

Wed, 15 Oct 2025
47 - From RIF to Reboot: A Guide for Early to Mid-Career Toxicologists

Tue, 30 Sep 2025
46 - Discussing the FDA's Announcement to Phase Out Animal Testing in Monoclonal Antibody Development

Thu, 17 Jul 2025
45 - Specialty Tox Topic: In Vivo Dermal Drug Development

Mon, 07 Jul 2025
44 - Specialty Tox Topic: In Vitro Dermal Drug Development

Mon, 23 Jun 2025
43 - Occupational Toxicology and Product Quality: Navigating Impurities and Occupational Safety

Mon, 05 May 2025
42 - The Past, Present, and Future of Safety Pharmacology

Tue, 01 Apr 2025
41 - Career Path: Toxicologist in the Food Industry

Mon, 03 Feb 2025
40 - Changing Approaches to Getting Drug Candidates into First-in-Human Clinical Trials: A Case Study

Wed, 18 Dec 2024
39 - Career Path: Pharmaceutical Consultant in the Field of Toxicology

Mon, 04 Nov 2024
38 - 3D Printing Emissions and Potential Health Effects from a Consumer Perspective

Mon, 02 Sep 2024
37 - Career Path: Pharmaceutical Consultant in the Field of Occupational, Environmental, and Quality Toxicology

Fri, 16 Aug 2024
36 - Discussions on Identifying Seizures Liability in Nonclinical Studies

Mon, 01 Jul 2024
35 - Alternative and Nontraditional Species Series: The Use of Transgenic and Disease Mouse Animal Models for Toxicology Studies

Mon, 06 May 2024
34 - Identifying an Appropriate Sponsor to Support Your Growth and Success in the Workplace

Mon, 04 Mar 2024
33 - Alternative and Nontraditional Species Series: Fertilized Egg Model as an Alternative Species for Safety Assessment Studies

Mon, 29 Jan 2024
32 - Alternative and Nontraditional Species Series: Advantages and Challenges of Using Rabbits

Mon, 22 Jan 2024
31 - Alternative and Nontraditional Species Series: Sheep as an Alternative Model for the Safety Evaluation of Medical Devices

Mon, 15 Jan 2024
30 - Alternative and Nontraditional Species Series: Mini Pig–Alternatives to Traditional Nonrodent Models in Nonclinical Safety Testing

Mon, 08 Jan 2024
29 - Medical Devices: Safety Evaluation and Becoming a Medical Device Toxicologist

Tue, 28 Nov 2023
28 - Interviewing and Negotiation 101 for Toxicologist Roles in the Biopharmaceutical Industry

Tue, 05 Sep 2023
27 - The History and Future of Oligonucleotide Drug Development

Wed, 05 Jul 2023
26 - The Opioid Crisis: Misconceptions, History, and Interventions

Fri, 28 Apr 2023
25 - Covid-19 Part 2: New Type of Antibody-Dependent Enhancement Associated with SARS-CoV-2 Virus: MIS-C, MIS-A, and MIS-N

Fri, 03 Mar 2023
24 - Covid-19 Part 1: Antibody-dependent Enhancement of Disease

Fri, 06 Jan 2023
23 - Artificial Intelligence (AI) Use in Toxicology

Thu, 03 Nov 2022
22 - Overview of mRNA Vaccines

Thu, 08 Sep 2022
21 - Tips for Taking the ABT Exam

Thu, 16 Jun 2022
20 - Moving from Minion to Manager

Thu, 26 May 2022
19 - Off the Beaten Path: The Nonclinical Development of Gene Therapy Products to Cure Monogenic Diseases

Thu, 24 Mar 2022
18 - Digital Pathology

Thu, 20 Jan 2022
17 - Expedited FDA Programs

Thu, 17 Jun 2021
16 - Toxicology Salary Survey

Thu, 13 May 2021
15 - Pediatric Drug Development

Thu, 04 Mar 2021
14 - CAR/T: New Modalities Paving the Way for Cancer

Wed, 06 Jan 2021
13 - History and Risk Assessment of Vaccines—Q&A

Thu, 05 Nov 2020
12 - Scientific Communication: Distilling and Rehearsing to Reach Your Audience

Thu, 20 Aug 2020
11 - AI and Big Data for Safety Testing

Mon, 27 Apr 2020
10 - Shining a Light on the Science and Strategy of Phototoxicity Assessments

Fri, 10 Apr 2020
9 - The Twists and Turns of GI Health and Medicine: An Interview with Dr. Alessio Fasano

Mon, 10 Feb 2020
8 - The Scientific Approach to Address Uncommon Routes and Best Practices for Forming a Working Group

Thu, 03 Oct 2019
7 - CRISPR Then and Now: An Interview with Dr. Jacob Corn, ACT 2015 Plenary Speaker

Fri, 16 Aug 2019
6 - In Vitro and Alternative Models for Regulatory Submission

Fri, 30 Nov 2018
5 - Regulation of E-Cigarettes

Thu, 19 Jul 2018
4 - The Opioid Epidemic

Thu, 26 Apr 2018
3 - Biomarkers

Wed, 27 Sep 2017
2 - Microbiome

Tue, 27 Jun 2017
1 - Oligonucleotide Therapeutics

Fri, 05 May 2017